Amarin Corp Plc (AMRN)

[ralphey]

HIKMA on generics

On Vascepa, it's difficult to say, but how I think is, I think Dr. Reddy's has been pretty vocal that they are coming to the market. I think the expectation was before the end of March, they would come to the market. I don't know their timing, but they talked about that they would bring this product to the market before the end of their financial year, which I think is the end of March. I think Teva has the approval in hand. I don't know what their situation. And then Apotex is the fourth filer. They don't have approval in hand. So it's difficult to say exactly how many players, but I wouldn't be surprised if there would be, maybe by the end of the year, 3 players. There is a possibility of the fourth, but I think the fourth player is highly, highly unlikely.